Mobile Transcranial Magnetic Stimulation for Depression
Official title: Portable Transcranial Magnetic Stimulation (TMS) in a Van for Treatment-Resistant Depression
Run by Medical University of South Carolina · NCT06748209 · Data updated 2026-11-12
This study is testing a new portable treatment for people with hard-to-treat depression to see if it can help them feel better while making it easier for them to access care.
Quick facts
| Phase | Phase 4 |
|---|---|
| Study type | Interventional |
| Ages | 22 Years to 80 Years |
| Sex | All |
| Enrollment | 30 (estimated) |
| Sponsor | Medical University of South Carolina Academic / other |
| Locations | 1 site (Charleston, South Carolina) |
| Status | Recruiting |
| Started | May 10, 2025 |
| Main results expected | March 1, 2027 |
| Study ends | March 1, 2028 |
| Registry record updated | May 6, 2026 |
| Trial ID | NCT06748209 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 22-80 with treatment-resistant depression who can communicate in English and provide consent.
✕Probably not a fit
Patients with unstable medical conditions, ferromagnetic metal in the head, or those who are pregnant may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This pilot study aims to develop and test a portable Transcranial Magnetic Stimulation (TMS) unit in a van, delivering treatment to patients with treatment-resistant major depression at three locations in South Carolina. The study will recruit up to 30 eligible patients who will receive accelerated TMS sessions over a two-week period. Investigators will assess the feasibility, safety, and efficacy of this mobile treatment approach, with the goal of improving access to TMS for patients who cannot access traditional treatment facilities. The findings will inform future research and potential widespread adoption of mobile TMS units.
Why it matters
Potential benefit: If successful, this approach could significantly increase access to effective TMS treatment for patients with treatment-resistant depression.
How similar studies have gone: While mobile TMS is a novel approach, similar studies have shown promise in improving access to mental health treatments.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adult (22-80 years old) * Have treatment-resistant depression as defined by the e-Mini, and the antidepressant treatment history form (ATHF short). * Be able to read and communicate in English. * Able to provide their own consent. * Access to a computer with videoconferencing ability for initial consent and telescreen. Exclusion Criteria: * Patients with unstable medical conditions that might make TMS unsafe. This includes current poorly controlled seizures. * Ferromagnetic metal in the head. * Pregnant. * Currently active substance abuse except tobacco.
Where it's running
-
Medical Univerity of South Carolina
Charleston, South Carolina, United States Recruiting
Study contacts
- Principal investigator: Mark George, MD — Medical University of South Carolina
- Study coordinator: Mark S George, MD
- Email: GEORGEM@MUSC.EDU
- Phone: 8438765142
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Sex differences in how cannabis affects people who regularly use it
This Phase 2 trial tests whether men and women who use cannabis several days a week respond differently to THC versus placebo.
-
taVNS added to oral motor training for babies with severe swallowing trouble
This trial tests whether pairing a noninvasive taVNS treatment with oral sensorimotor training helps infants in NICUs swallow better and feed more safely.
-
Personalized chemoimmunotherapy for early TNBC with high TILs (no anthracyclines upfront)
This trial tests a 12-week, anthracycline-free neoadjuvant regimen of carboplatin, paclitaxel, and pembrolizumab in early-stage TNBC with high TILs to see if surgery outcomes are as good as historical regimens.
-
Parietal brain stimulation for memory in Parkinson’s with mild cognitive impairment
This study tests whether a short, high-dose burst of brain stimulation to the right superior parietal area can safely and feasibly help people with Parkinson’s-related cognitive impairment.
-
Smell training plus non-invasive nerve stimulation to boost sense of smell
This test will try adding non-invasive trigeminal nerve stimulation to standard smell training for adults with smell loss to see if it improves olfactory function.
-
Olfactory-focused low-intensity ultrasound on smell perception in healthy adults
This study tests whether gentle, targeted ultrasound can change how healthy adults perceive odors and respond to them.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.